At the news
? BEARISHIMPACT 6/10 PRESS-RELEASE filed Jun 2, 2026 at 07:00 ET
Bioventus (BVS) reported Q1 2026 EPS of $0.15, a 30.6% miss versus the $0.22 consensus, on revenue of $155.4M (in line with the $155.4M estimate). The press release focuses on an upcoming conference appearance, not guidance or operational details, leaving the miss as the primary takeaway.
- Q1 2026 EPS of $0.15 missed consensus of $0.22 by 30.6%
- Revenue of $155.4M was in line with consensus of $155.4M
- No guidance update or operational commentary provided in the release
- CFO to present at Goldman Sachs Global Healthcare Conference on June 8, 2026
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access